Project Number 1UF1AG046148-01 Agency/Funding Organization NIA Funding Year 2013 View Full Project Details for ALLOPREGNANOLONE REGENERATIVE THERAPEUTIC FOR MCI/AD: DOSE FINDING PHASE I Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) r. Multi-target Researcher and Organization Principal Investigator BRINTON, ROBERTA EILEEN Principal Investigator First Name ROBERTA Principal Investigator Last Name BRINTON Awardee Organization UNIVERSITY OF SOUTHERN CALIFORNIA Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-13-016: Alzheimer's Disease Phase I Clinical Trials (R01) FY Overall Cost $2,429,633 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M Related Resources Clinical Trial Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD
